Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists

被引：10

作者：

Ward, Simon E. ^{[1
]}

Eddershaw, Peter J. ^{[1
]}

Scott, Claire M. ^{[1
]}

Gordon, Laurie J. ^{[1
]}

Lovell, Peter J. ^{[1
]}

Moore, Susan H. ^{[1
]}

Smith, Paul W. ^{[1
]}

Starr, Kathryn R. ^{[1
]}

Thewlis, Kevin M. ^{[1
]}

Watson, Jeannette M. ^{[1
]}

机构：

[1] GlaxoSmithKline, Psychiat Ctr Excellence Drug Discovery & Mol Disc, Harlow CM19 5AW, Essex, England

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2008年 / 51卷 / 10期

关键词：

D O I：

10.1021/jm8001444

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

5-HT1 receptor antagonists have been discovered with good selectivity over the 5-HT transporter. This is the first report of highly potent, selective ligands for the 5-HT1A/B/D receptors with low intrinsic activity, which represent a useful set of molecules for further understanding the roles of the 5-HT1 receptor subtypes and providing new approaches,for the treatment of depression.

引用

页码：2887 / 2890

页数：4

共 50 条

[1] Discovery of Potent, Orally Bioavailable Phthalazinone Bradykinin B1 Receptor Antagonists
Biswas, Kaustav
Peterkin, Tanya A. N.
Bryan, Marian C.
Arik, Leyla
Lehto, Sonya G.
Sun, Hong
Hsieh, Feng-Yin
Xu, Cen
Fremeau, Robert T.
Allen, Jennifer R.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (20) : 7232 - 7246
[2] Discovery of potent, orally bioavailable CCR5 antagonists - 1.
Tagat, J
Nazareno, D
Vice, S
Lin, S
Steensma, R
Miller, M
Bauer, A
McCombie, S
Palani, A
Josien, H
Clader, J
Neustadt, B
Greenlee, W
Ganguly, A
Piwinski, J
Chan, TM
Evans, A
Dan, N
Baroudy, B
Endres, M
Strizki, J
Vantuno, N
Cox, K
Broske, L
Zhang, X
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U5 - U5
[3] Discovery of potent and orally bioavailable phthalazinone Bradykinin B1 receptor antagonists for chronic pain
Biswas, Kaustav
Peterkin, Tanya A. N.
Bryan, Marian C.
Arik, Leyla
Lehto, Sonya G.
Sun, Hong
Hsieh, Feng-Yin
Xu, Cen
Fremeau, Robert T.
Allen, Jennifer R.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[4] Discovery of a Potent and Orally Bioavailable Zwitterionic Series of Selective Estrogen Receptor Degrader-Antagonists
Scott, James S.
Stead, Darren
Barlaam, Bernard
Breed, Jason
Carbajo, Rodrigo J.
Chiarparin, Elisabetta
Cureton, Natalie
Davey, Paul R. J.
Fisher, David I.
Gangl, Eric T.
Grebe, Tyler
Greenwood, Ryan D.
Hande, Sudhir
Hatoum-Mokdad, Holia
Hughes, Samantha J.
Hunt, Thomas A.
Johnson, Tony
Kavanagh, Stefan L.
Klinowska, Teresa C. M.
Larner, Carrie J. B.
Lawson, Mandy
Lister, Andrew S.
Longmire, David
Marden, Stacey
McGuire, Thomas M.
McMillan, Caroline
McMurray, Lindsay
Morrow, Christopher J.
Nissink, J. Willem M.
Moss, Thomas A.
O'Donovan, Daniel H.
Polanski, Radoslaw
Stokes, Stephen
Thakur, Kumar
Trueman, Dawn
Truman, Caroline
Tucker, Michael J.
Wang, Haixia
Whalley, Nicky
Wu, Dedong
Wu, Ye
Yang, Bin
Yang, Wenzhan
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2023, : 2918 - 2945
[5] THE DESIGN OF SELECTIVE 5-HT1A RECEPTOR ANTAGONISTS
CLIFFE, IA
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 30 - MEDI
[6] The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidine
Lin, Peter
Chang, Lehua
DeVita, Robert J.
Young, Jonathan R.
Eid, Ronsar
Tong, Xinchun
Zheng, Song
Ball, Richard G.
Tsou, Nancy N.
Chicchi, Gary G.
Kurtz, Marc M.
Tsao, Kwel-Lan C.
Wheeldon, Alan
Carlson, Emma J.
Eng, WaiSi
Burns, H. Donald
Hargreaves, Richard J.
Mills, Sander G.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5191 - 5198
[7] ORGN 54-Discovery of potent, selective, and orally bioavailable antagonists of CC Chemokine Receptor 2
Carter, Percy H.
Brown, Gregory D.
Nelson, David J.
Cherney, Robert J.
Duncia, John V.
Santella, Joseph B., III
Gardner, Daniel S.
Cvijic, Mary Ellen
Mandlekar, Sandhya
Tebben, Andrew J.
Zhao, Qihong
Decicco, Carl P.
Barrish, Joel C.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
[8] Discovery of potent, selective and orally bioavailable growth hormone secretagogue receptor (Ghs-R) antagonists
Xin, ZL
Serby, MD
Zhao, HY
Liu, M
Liu, B
Hutchins, CW
Sarris, K
Ethan, H
Falls, DH
Collins, CA
Lin, CW
Ogiela, CA
Brune, ME
Bush, G
Droz, B
Fey, T
Knourek-Segel, V
Shapiro, R
Jacobson, P
Beno, D
Turner, T
Sham, HL
Liu, G
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2544 - U2544
[9] Discovery of potent, orally bioavailable protease-activated receptor 4 antagonists
Marinier, Anne
Banville, Jacques
Bird, Eileen
Callejo, Mario
Deon, Daniel
Dube, Laurence
Gagnon, Marc
Giancarli, Mary
Guy, Julia
Harper, Tim
Lam, Patrick
Lavallee, Jean-Francois
Lawrence, Michael
Martel, Alain
Miller, Michael
O'Grady, Harold
Posy, Shoshana
Priestley, Scott
Remillard, Roger
Ruediger, Edward
Tremblay, Francois
Watson, Carol
Wong, Pancras
Yang, Jing
Bouvier, Michel
Seiffert, Dietmar
Wexler, Ruth
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[10] Discovery of orally bioavailable NK1 receptor antagonists
Genicot, C
Christophe, B
Collart, P
Gillard, M
Goossens, L
Hénichart, JP
Lassoie, MA
Moureau, F
Neuwels, M
Nicolas, JM
Pasau, P
Quéré, L
Ryckmans, T
Stiernet, F
Taverne, T
Van Keulen, BJ
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 437 - 442

← 1 2 3 4 5 →